As expected, FATP5 knockdown significantly promoted HCC tumorigenesis, as revealed by a higher tumor growth rate and a larger maximum tumor size, whereas AMPK activation by metformin reduced the tumor burden of mice in the Huh7-shFATP5 group (Fig. 5D–F). The gene discussed is SLC27A5; the disease is hepatocellular carcinoma.